Reliability and Variability of Ki-67 Digital Image Analysis Methods for Clinical Diagnostics in Breast Cancer.

Biomarker Breast Cancer Digital Pathology Image Analysis Ki-67

Journal

Laboratory investigation; a journal of technical methods and pathology
ISSN: 1530-0307
Titre abrégé: Lab Invest
Pays: United States
ID NLM: 0376617

Informations de publication

Date de publication:
25 Jan 2024
Historique:
received: 01 03 2023
revised: 20 11 2023
accepted: 19 01 2024
medline: 28 1 2024
pubmed: 28 1 2024
entrez: 27 1 2024
Statut: aheadofprint

Résumé

Ki-67 is a nuclear protein associated with proliferation, and a strong potential biomarker in breast cancer, but is not routinely measured in current clinical management due to a lack of standardization. Digital image analysis (DIA) is a promising technology that could allow high throughput analysis and standardization. There is a dearth of data on the clinical reliability as well as intra- and inter-algorithmic variability of different DIA methods. In this study, we scored and compared a set of breast cancer cases in which manually counted Ki-67 has already been demonstrated to have prognostic value (n=278) to five DIA methods; namely, Aperio ePathology, Definiens Tissue Studio, Qupath, an unsupervised IHC color histogram (IHCCH) algorithm and a deep learning pipeline piNET. The piNET system achieved high agreement (ICC: 0.850) and correlation (R= 0.85) with the reference score. The Qupath algorithm exhibited a high degree of reproducibility between all rater instances (ICC: 0.889). Although piNET performed well against absolute manual counts, none of the tested DIA methods classified common Ki-67 cutoffs with high agreement or reached the clinically relevant Cohen's kappa of at least 0.8. The highest agreement achieved was Cohen's kappa statistic of 0.73 for cutoffs 20% and 25% by the piNET system. The main contributors to inter-algorithmic variation and poor cutoff characterization included heterogeneous tumor biology, varying algorithm implementation, and setting assignments. It appears that image segmentation is the primary explanation for semi-automated intra-algorithmic variation, which involves significant manual intervention to correct. Automated pipelines such as piNET may be crucial in developing robust and reproducible unbiased DIA approaches to accurately quantify Ki-67 for clinical diagnosis in the future.

Identifiants

pubmed: 38280634
pii: S0023-6837(24)00019-9
doi: 10.1016/j.labinv.2024.100341
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100341

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Melanie Dawe (M)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Wei Shi (W)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Tian Yu Liu (TY)

Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada.

Katherine Lajkosz (K)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Yukiko Shibahara (Y)

Laboratory Medicine Program, University Health Network, Toronto, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada.

Nakita E K Gopal (NEK)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada.

Rokshana Geread (R)

Department of Electrical, Computer and Biomedical Engineering, Toronto Metropolitan University, Toronto, Canada.

Seyed Mirjahanmardi (S)

Department of Electrical, Computer and Biomedical Engineering, Toronto Metropolitan University, Toronto, Canada.

Carrie X Wei (CX)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Sehrish Butt (S)

STTARR Innovation Centre, University Health Network, Toronto, Canada.

Moustafa Abdalla (M)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Sabrina Manolescu (S)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Sheng-Ben Liang (SB)

Princess Margaret Cancer Biobank (PMCB), University Health Network, Toronto, Canada.

Dianne Chadwick (D)

Laboratory Medicine Program, University Health Network, Toronto, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada; Princess Margaret Cancer Biobank (PMCB), University Health Network, Toronto, Canada; Ontario Tumour Bank, Ontario Institute for Cancer Research, Toronto, Canada.

Michael H A Roehrl (MHA)

Laboratory Medicine Program, University Health Network, Toronto, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada; Princess Margaret Cancer Biobank (PMCB), University Health Network, Toronto, Canada; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA.

Trevor D McKee (TD)

STTARR Innovation Centre, University Health Network, Toronto, Canada.

Adewunmi Adeoye (A)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

David McCready (D)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

April Khademi (A)

Department of Electrical, Computer and Biomedical Engineering, Toronto Metropolitan University, Toronto, Canada; St. Michael's Hospital, Unity Health Network, Toronto, Canada.

Fei-Fei Liu (FF)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Anthony Fyles (A)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Susan J Done (SJ)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Laboratory Medicine Program, University Health Network, Toronto, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada. Electronic address: susan.done@uhn.ca.

Classifications MeSH